Correlation Between Oncorus and Tff Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Oncorus and Tff Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Tff Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Tff Pharmaceuticals, you can compare the effects of market volatilities on Oncorus and Tff Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Tff Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Tff Pharmaceuticals.
Diversification Opportunities for Oncorus and Tff Pharmaceuticals
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Oncorus and Tff is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Tff Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tff Pharmaceuticals and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Tff Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tff Pharmaceuticals has no effect on the direction of Oncorus i.e., Oncorus and Tff Pharmaceuticals go up and down completely randomly.
Pair Corralation between Oncorus and Tff Pharmaceuticals
Given the investment horizon of 90 days Oncorus is expected to under-perform the Tff Pharmaceuticals. In addition to that, Oncorus is 3.62 times more volatile than Tff Pharmaceuticals. It trades about -0.15 of its total potential returns per unit of risk. Tff Pharmaceuticals is currently generating about -0.07 per unit of volatility. If you would invest 1,198 in Tff Pharmaceuticals on August 31, 2024 and sell it today you would lose (1,164) from holding Tff Pharmaceuticals or give up 97.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 2.94% |
| Values | Daily Returns |
Oncorus vs. Tff Pharmaceuticals
Performance |
| Timeline |
| Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Tff Pharmaceuticals |
Oncorus and Tff Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncorus and Tff Pharmaceuticals
The main advantage of trading using opposite Oncorus and Tff Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Tff Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will offset losses from the drop in Tff Pharmaceuticals' long position.| Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
| Tff Pharmaceuticals vs. Cue Biopharma | Tff Pharmaceuticals vs. Eliem Therapeutics | Tff Pharmaceuticals vs. Inhibrx | Tff Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |